← Back to Search

Critical Pathway for Heart Failure (CAPTURE Trial)

N/A
Waitlist Available
Led By C Kerr, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

CAPTURE Trial Summary

The purpose of this study is to develop and implement a critical pathway to identify patients with ischemic cardiomyopathy who are candidates for an implantable cardioverter-defibrillator (ICD). This study will also determine whether the use of the critical pathway for ICDs is associated with a change in the ICD referral and implantation rate.

Eligible Conditions
  • Heart Failure
  • Heart Attack

CAPTURE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Referral for ICD Assessment
Secondary outcome measures
Rate of ICD Implantation

CAPTURE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Critical PathwayExperimental Treatment1 Intervention
Group II: Standard PracticeActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,416 Total Patients Enrolled
8 Trials studying Heart Failure
5,166 Patients Enrolled for Heart Failure
S Cowan, MD, MScStudy DirectorSt. Paul's Hospital, Vancouver, British Columbia
C Kerr, MDPrincipal InvestigatorSt. Paul's Hospital, Vancouver, British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy
2012. "A Critical Pathway for Implantable Cardioverter-Defibrillators in Patients With Ischemic Cardiomyopathy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01248702.
All > Anterior Ischemic Optic Neuropathy
~46 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top